- Supported exchanges /
- TWO /
- 6932.TWO
Mercury Biopharmaceutical Corporation (6932 TWO) stock market data APIs
Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.
Mercury Biopharmaceutical Corporation Financial Data Overview
| 14.75 | |
| 15.05 | |
| - | |
| 15.05 | |
| 14.7 | |
| 10.1-22.25 | |
| 6 105 M | |
| 414 M | |
| 5 750 K | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Mercury Biopharmaceutical Corporation Fundamental Data is available in our Financial Data APIs
- Net Revenue 5 750 K
- EBITDA -42 294 000
- Earnings Per Share -0.1
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Mercury Biopharmaceutical Corporation Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Mercury Biopharmaceutical Corporation End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
